lobbying_activities: 3486262

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3486262	a490ce4c-11d9-4f6a-98ef-98c31d958820	Q4	S-3 GROUP	400774330	VIATRIS (MYLAN, INC)	2025	fourth_quarter	CPT	Issues related to patent policy and reform, including to address patent thickets and FDA/PTO Coordination; S.527 Prescription Pricing for the People Act; S.1096 Preserve Access to Affordable Generics and Biosimilars Act; S.1041 Affordable Prescriptions for Patients Act	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2026-01-15T13:31:09-05:00